This story has been updated to reflect a correction made by the company regarding the percentage of existing share capital represented by the new shares.

NEW YORK (GenomeWeb News) – Osmetech has filed with the London Stock Exchange for a proposed private placement of shares that would raise gross proceeds of £9.8 million ($16.3 million).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.